A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma

Схожие документы

• Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis
  по: Hong, Junshik, et al.
  Опубликовано: (2010)
• R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma
  по: Lamy, Thierry, et al.
  Опубликовано: (2018)
• The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
  по: T. D. Lutskaya, et al.
  Опубликовано: (2014-07-01)
• The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era
  по: Cassidy, R. J., et al.
  Опубликовано: (2016)
• Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
  по: Papageorgiou, Sotirios G., et al.
  Опубликовано: (2021)